Litcius/Paper detail

Engineering Extracellular Vesicles Mimetics for Targeted Chemotherapy of Drug-Resistant Ovary Cancer

Xiaoguang Liu, Guangquan Liu, Yinghua Mao, Jie Luo, Yongping Cao, Weilong Tan, Wenhao Li, Huanhuan Yu, Xuemei Jia, Hong Li

2023Nanomedicine11 citationsDOI

Abstract

Aim: To develop nanocarriers for targeting the delivery of chemotherapeutics to overcome multidrug-resistant ovarian cancer. Materials & methods: Doxorubicin-loaded nanovesicles were obtained through serial extrusion, followed by loading of P-glycoprotein siRNA and folic acid. The targeting ability and anticancer efficacy of the nanovesicles were evaluated. Results: The doxorubicin-loaded nanovesicles showed a high production yield. The presence of P-glycoprotein siRNA and folic acid resulted in reversed drug resistance and tumor targeting. This nanoplatform tremendously inhibited the viability of multidrug-resistant ovarian cancer cells, which was able to target tumor tissue and suppress tumor growth without adverse effects. Conclusion: These bioengineered nanovesicles could serve as novel extracellular vesicles mimetics for chemotherapeutics delivery to overcome multidrug resistance.

Topics & Concepts

NanocarriersDoxorubicinMultiple drug resistanceDrug deliveryOvarian cancerDrug resistancePharmacologyCancer researchTargeted drug deliveryChemistryCancer cellChemotherapyDrugCancerMedicineBiologyInternal medicineMicrobiologyOrganic chemistryRNA Interference and Gene DeliveryExtracellular vesicles in diseaseMicroRNA in disease regulation
Engineering Extracellular Vesicles Mimetics for Targeted Chemotherapy of Drug-Resistant Ovary Cancer | Litcius